Cargando…
COP Cells and Tissue Loss Syndromes: Frailty, Sarcopenia, and Osteoporosis
COP cells have been identified as having a potential role in the pathogenesis of tissue loss syndromes such as osteoporosis and frailty. This is based on the hypothesis that their dysregulation may cause a decrease in bone and muscle formation, which also increase the risk of adverse outcomes such a...
Autor principal: | Duque, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679707/ http://dx.doi.org/10.1093/geroni/igab046.168 |
Ejemplares similares
-
The Role of the Kynurenine Pathway in the Pathophysiology of Frailty, Sarcopenia, and Osteoporosis
por: Ballesteros, Juan, et al.
Publicado: (2023) -
A New Type of COP: The Role of Circulating Osteoprogenitor (COP) Cells in Health and Disease
por: Duque, Gustavo
Publicado: (2021) -
Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
por: Greco, Emanuela A., et al.
Publicado: (2019) -
Sarcopenia and Frailty: Challenges in Mainstream Nephrology Practice
por: Wong, Limy, et al.
Publicado: (2021) -
The Biology of COP Cells: Mesenchymal of Hematopoietic?
por: McGee-Lawrence, Meghan
Publicado: (2021)